Literature DB >> 30723639

Escherichia coli Bacteremia-induced Purpura Fulminans: A Case Report.

Mohamed Ahmed1, Michael Samotowka2, Saba Habis3, Ahmed Mahmoud1, Rasha Saeed4.   

Abstract

Purpura fulminans (PF) is a dermatologic manifestation of an underlying life-threatening condition associated with disseminated intravascular coagulation and skin necrosis. The known categories include protein C deficiency or abnormalities of other coagulation systems (inherited or acquired), acute infectious PF and idiopathic. We describe a case of PF induced by Escherichia coli-associated bacteremia.

Entities:  

Keywords:  disseminated intravascular coagulation; escherichia coli; purpura fulminans

Year:  2018        PMID： 30723639      PMCID： PMC6351005          DOI： 10.7759/cureus.3638

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  12 in total

1.  Purpura fulminans due to E. coli septicemia.

Authors:  Georg M Huemer; Hugo Bonatti; Karin M Dunst
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

Review 2.  Acquired purpura fulminans.

Authors:  R B Francis
Journal:  Semin Thromb Hemost       Date:  1990-10       Impact factor: 4.180

3.  Bad to worse.

Authors:  Yigal Helviz; Moshe Hersch; Lev Shmuelevitz; Jawad Atrash; Sharon Einav
Journal:  Am J Med       Date:  2011-03       Impact factor: 4.965

4.  Group A Escherichia coli-related purpura fulminans: an unusual manifestation due to an unusual strain?

Authors:  Marlène Amara; Stéphane Bonacorsi; Jérôme Bedel; Jean-Paul Mira; Virginie Laurent; Koryna Socha; Fabrice Bruneel; Béatrice Pangon; Jean-Pierre Bédos; David Grimaldi
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

5.  Effect of the Factor V Leiden mutation on the severity of meningococcal disease.

Authors:  S Kondaveeti; M L Hibberd; R Booy; S Nadel; M Levin
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

6.  Review of management of purpura fulminans and two case reports.

Authors:  J Nolan; R Sinclair
Journal:  Br J Anaesth       Date:  2001-04       Impact factor: 9.166

7.  Protein C substitution in sepsis-associated purpura fulminans.

Authors:  E Rintala; M Kauppila; O P Seppälä; L M Voipio-Pulkki; V Pettilä; V Rasi; P Kotilainen
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

8.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

Authors:  M E A de Kraker; V Jarlier; J C M Monen; O E Heuer; N van de Sande; H Grundmann
Journal:  Clin Microbiol Infect       Date:  2012-10-08       Impact factor: 8.067

Review 9.  Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Authors:  Thomas A Russo; James R Johnson
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

10.  Thoracic epidural analgesia with low concentration of bupivacaine induces thoracic and lumbar sympathetic block: a randomized, double-blind clinical trial.

Authors:  Hendrik Freise; Andreas Meissner; Stefan Lauer; Björn Ellger; Robert Radke; Mathias Bruewer; Gerd Brodner; Hugo K Van Aken; Andreas W Sielenkämper; Lars G Fischer
Journal:  Anesthesiology       Date:  2008-12       Impact factor: 7.892
View more
  2 in total

1.  Purpura Fulminans in a Patient With Septic Shock due to Escherichia coli Bacteremia With Emphysematous Pyelitis.

Authors:  Maria Del Mar Morales Hernandez; Michael Carranza; Bijal Patel; Joshua Calvert; Ghania Masri
Journal:  Cureus       Date:  2021-02-09

2.  A Rare Cause of a Rare Disorder: E. coli-Induced Purpura Fulminans Secondary to Urinary Tract Infection.

Authors:  Jacob Lowry; Edva Noel
Journal:  Case Rep Crit Care       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.